Status: Not yet recruiting
Entinostat & Chemotherapy for Locally Advanced or Metastatic Bladder Cancer
This single-center single-arm, open-label prospective clinical trial aimed to evaluate the efficacy and safety of entinostat combined with chemotherapy as second-line therapy for unresectable locally advanced or metastatic bladder cancer.
Participants needed: 29
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolUpdated: Dec 3, 2025Locations: 1
Eligibility criteria
Histopathologic confirmed unresectable advanced or metastatic bladder cancer, ex... [+7]
Patients who received platinum-based chemotherapy after failure of first-line tr... [+5]